B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

GPX1

MOLECULAR TARGET

glutathione peroxidase 1

NCBI Gene: 287623 compounds

GPX1 (glutathione peroxidase 1) is targeted by 23 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting GPX1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1amlexanox1.102
2DEAD-box RNA Helicases0.691
3Thioctic Acid0.691
4vinpocetine0.691
5cefatrizine0.691
6Cefazolin0.691
7Cefdinir0.691
8Cefixime0.691
9Cefmenoxime0.691
10Cefotetan0.691
11Cefoxitin0.691
12Cefpodoxime0.691
13Cefprozil0.691
14ceftazidime0.691
15Ceftibuten0.691
16Cephaloglycin0.691
17Dipyrone0.691
18Dithiazanine 3-Ethyl-2-(5-(3-ethyl-2-benzothiazolinylidene)-1,3- pentadienyl)benzothiazolium.0.691
19Doxazosin0.691
20Irinotecan0.691
21silver sulfadiazine0.691
22stx640.691
23Thioctic Acid0.691

About GPX1 as a Drug Target

GPX1 (glutathione peroxidase 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 23 compounds with documented GPX1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

GPX1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.